Our Vision: A Center of Excellence in Cancer Care
At Crescent Theranostics, our vision is to become a premier Center of Excellence and leading medical destination for patients battling prostate and other advanced cancers. Through our recognized research and precision therapy programs, we offer access to some of the most innovative and individualized treatments available today.
Patients from across the U.S. entrust Crescent Theranostics with their cancer care, drawn by our reputation for clinical expertise, compassion, and outcomes-driven treatment.
Every patient is supported by a dedicated, multidisciplinary team united by a single purpose: to deliver exceptional, personalized care. We combine evidence-based therapies with heartfelt compassion, comprehensive patient education, and a relentless commitment to improving both survival and quality of life.
what is Crescent Theranostics?
Crescent Theranostics, with locations in Anaheim and Temecula, CA, is Southern California’s premier outpatient center specializing in theranostic cancer care—a groundbreaking approach that combines targeted therapy with advanced diagnostics. Founded on the belief that every patient deserves precise, compassionate, and personalized treatment, Crescent Theranostics is redefining how prostate cancer and neuroendocrine tumors are managed outside of hospital or research settings.
The clinic offers FDA-approved radioligand therapies, including Pluvicto for metastatic castration-resistant prostate cancer and Lutathera for gastroenteropancreatic neuroendocrine tumors. These treatments deliver radiation directly to cancer cells with remarkable accuracy, helping patients achieve better outcomes with fewer side effects—and all within the comfort of a supportive outpatient environment.
By combining clinical excellence with a deeply human approach, Crescent Theranostics empowers patients at every stage of their journey—offering life-extending treatments, personalized care, and hope in the face of complex disease.
What Is Theranostics?
Theranostics is a groundbreaking approach in modern medicine that seamlessly integrates diagnostic imaging with targeted therapy—enabling clinicians to detect and treat disease with unprecedented precision. Using specialized radioactive compounds, theranostics allows physicians to visualize cancer cells in real time and deliver therapy directly to those same cells, all in a single, streamlined process.
This dual-function strategy is transforming care for patients with challenging or advanced cancers, including metastatic prostate cancer and gastroenteropancreatic neuroendocrine tumors (GEP-NETs). By selectively targeting tumor cells and minimizing damage to healthy tissue, theranostics offers a more personalized, effective, and tolerable alternative to traditional treatments.
At its core, theranostics empowers a new era of precision oncology—where treatment is as smart as it is powerful.
Why choose Crescent Theranostics?
At Crescent Theranostics, we redefine cancer care by offering Southern California’s only outpatient center fully dedicated to theranostics—a next-generation approach that unites precision diagnostics with targeted radioligand therapies.
Our clinic is designed around you—the patient. We provide leading-edge, FDA-approved treatments in a serene, comfortable outpatient setting—delivering the highest standard of care without the burden of a hospital visit. Our current therapies include Pluvicto® and Lutathera®, with additional breakthrough treatments on the horizon.
More than a treatment center, Crescent Theranostics is a partner in your care journey. From initial consultation through long-term follow-up, we empower patients to take an active role in their treatment plan. This personalized, collaborative approach fosters trust, enhances communication, and ultimately leads to more meaningful outcomes.
Discover a place where advanced science meets compassionate care—on your terms.
Conditions We Treat
At Crescent Theranostics, the team addresses a broad spectrum of conditions, including:
Advanced Treatment for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
At Crescent Theranostics, we offer cutting-edge care for men with metastatic castration-resistant prostate cancer through Pluvicto™, an FDA-approved radioligand therapy. Administered conveniently via intravenous push in our modern outpatient facility, Pluvicto is designed to deliver targeted radiation directly to prostate cancer cells—sparing surrounding healthy tissue. This innovative therapy not only helps alleviate symptoms but also works to slow the progression of advanced disease, offering renewed hope for patients facing limited treatment options.
Targeted Radiotherapy for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
- Crescent Theranostics proudly offers Lutathera®, an advanced radioligand therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This precision treatment delivers targeted radiation directly to tumor cells, helping to control disease while preserving healthy tissue. Administered as an outpatient infusion over several hours, Lutathera is both effective and well-tolerated—providing patients with a state-of-the-art therapeutic option in a comfortable, compassionate setting.
- Differentiated Thyroid Cancer (DTC)
For patients with recurrent or metastatic disease not responsive to traditional therapies, we offer I-131 radioactive iodine treatment in a supportive outpatient environment. - Graves’ Disease and Hyperthyroidism
Treated with I-131 radioiodine therapy, offering a non-surgical, definitive option to manage overactive thyroid function safely and effectively.
Contact Information & Locations
Crescent Theranostics proudly serves patients from across the region with two convenient outpatient locations in Anaheim and Temecula, California. Our team is here to guide you through every step—from scheduling your first consultation to understanding insurance and preparing for treatment.
Anaheim Office
2050 South Euclid Street, Anaheim, CA 92802
Temecula Office
27262 Via Industria, Temecula, CA 92590
To schedule an appointment, learn more about Pluvicto, Lutathera, or our upcoming treatment options, contact us by phone or visit our website. We’re here to answer your questions and help you take the next step toward personalized, life-changing cancer care.
For more information, you can visit their website directly or contact Crescent Theranostics for appointment scheduling and inquiries about available treatments.